Phase III Win in Schizophrenia; Bipolar Blood Test; How Do Psychedelics Work?

The 50-mg dose of the investigational drug brilaroxazine significantly reduced symptoms of schizophrenia in adults within 4 weeks in the phase III RECOVER trial, developer Reviva Pharmaceuticals announced.

Severe mental illness was linked with a 50% higher risk of death following COVID infection. (British Journal of Psychiatry)

A simple blood test may bolster the differential diagnosis of mood disorders, like bipolar disorder versus major depressive disorder. (JAMA Psychiatry)

The proportion of children and adolescents who received mental health counseling or therapy increased from 10% in 2019 to 13.8% in 2022, CDC data showed.

Exactly how do psychedelics work as psychiatric therapeutics? (Nature)

Among schoolkids in the same grade diagnosed with ADHD, those of younger age were just as likely to retain their diagnosis over time as their older classmates. (Lancet Psychiatry)

Twice as many parents of kids ages 9 to 15 reported concerns about internet addiction compared with substance addiction. (JAMA Network Open)

Former President Donald Trump called for the return of “mental institutions” as a way to reduce homelessness, if elected to a second term. (Axios)

More mental health professionals are coming to Medicare. (Washington Post)

Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.

Juul’s internal playbook opens a rare window into influence in Washington

WASHINGTON — A new trove of internal emails and other documents from the e-cigarette maker Juul reveals the company’s extensive behind-the-scenes efforts to promote its

February 15, 2024

Breaking Political Boundaries: The Surprising Political Consensus on Psychedelics | Psychedelic Invest

Once upon a time, psychedelic legalization was an issue exclusive to ultra-liberals in the United States. That time has come and gone. Both sides of

June 15, 2023

Addressing Juvenile Generalized Myasthenia Gravis

Generalized myasthenia gravis (gMG) is a rare condition, especially in youth. However, evidence is beginning to accrue for management of juvenile cases. Prevalence increases with

December 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.